Faron Pharmaceuticals "confirms promising results from first cohort"
News release
by
Faron Pharmaceuticals Oy
London, UK
|
April 24, 2023 03:00 AM Eastern Daylight Time
Faron Pharmaceuticals Chief Medical Officer Marie-Louise Fjällskog speaks to Proactive about progress on the clinical stage biopharmaceutical company's BEXMAB study.
Fjällskog "confirms promising results from the first cohort" and highlights plans to go to the FDA "very soon" to share the company's plan for "getting into an accelerated approval pathway".
Contact Details
Proactive UK Ltd
+44 20 7989 0813
